Page last updated: 2024-08-21

cupric sulfide and Angiogenesis, Pathologic

cupric sulfide has been researched along with Angiogenesis, Pathologic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, Z; Lao, X; Li, B; Wang, Y; Xie, D1
Cai, W; Chen, F; Ehlerding, EB; Goel, S; Graves, SA; Hong, H; Nickles, RJ; Orbay, H; Shi, S; Theuer, CP1

Other Studies

2 other study(ies) available for cupric sulfide and Angiogenesis, Pathologic

ArticleYear
Cetuximab-modified CuS nanoparticles integrating near-infrared-II-responsive photothermal therapy and anti-vessel treatment.
    International journal of nanomedicine, 2018, Volume: 13

    Topics: Animals; Cell Death; Cell Line, Tumor; Cetuximab; Chickens; Copper; Endocytosis; Female; Fluorescence; Human Umbilical Vein Endothelial Cells; Humans; Hyperthermia, Induced; Infrared Rays; Mice, Nude; Nanoparticles; Neoplasms; Neovascularization, Pathologic; Phototherapy

2018
In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine.
    ACS nano, 2015, Volume: 9, Issue:4

    Topics: Ablation Techniques; Animals; Antineoplastic Agents; Copper; Drug Carriers; Endoglin; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Intracellular Signaling Peptides and Proteins; Mammary Neoplasms, Experimental; Mice; Nanostructures; Neovascularization, Pathologic; Polyethylene Glycols; Porosity; Positron-Emission Tomography; Silicon Dioxide; Theranostic Nanomedicine; Tissue Distribution

2015